These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34045187)

  • 61. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
    Faugeroux V; Lefebvre C; Pailler E; Pierron V; Marcaillou C; Tourlet S; Billiot F; Dogan S; Oulhen M; Vielh P; Rameau P; NgoCamus M; Massard C; Laplace-Builhé C; Tibbe A; Taylor M; Soria JC; Fizazi K; Loriot Y; Julien S; Farace F
    Eur Urol Oncol; 2020 Aug; 3(4):498-508. PubMed ID: 31412010
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.
    Shao C; Liao CP; Hu P; Chu CY; Zhang L; Bui MH; Ng CS; Josephson DY; Knudsen B; Tighiouart M; Kim HL; Zhau HE; Chung LW; Wang R; Posadas EM
    PLoS One; 2014; 9(2):e88967. PubMed ID: 24551200
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells.
    Huaman J; Naidoo M; Zang X; Ogunwobi OO
    Cells; 2019 Jun; 8(6):. PubMed ID: 31226820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
    Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
    Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
    Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
    Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
    PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
    Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
    Lu J; Fan T; Zhao Q; Zeng W; Zaslavsky E; Chen JJ; Frohman MA; Golightly MG; Madajewicz S; Chen WT
    Int J Cancer; 2010 Feb; 126(3):669-83. PubMed ID: 19662651
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation.
    Huang Q; Li S; Hu X; Sun M; Wu Q; Dai H; Tan Y; Sun F; Wang C; Rong X; Liao W; Peng J; Xiao J; Huang L; Wang J; Liang B; Lin K; Liu Y; Shi M
    J Exp Clin Cancer Res; 2020 Jan; 39(1):25. PubMed ID: 32000836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular biomarker analyses using circulating tumor cells.
    Punnoose EA; Atwal SK; Spoerke JM; Savage H; Pandita A; Yeh RF; Pirzkall A; Fine BM; Amler LC; Chen DS; Lackner MR
    PLoS One; 2010 Sep; 5(9):e12517. PubMed ID: 20838621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy.
    Okegawa T; Itaya N; Hara H; Tambo M; Nutahara K
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916908
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models.
    Hassan S; Blick T; Wood J; Thompson EW; Williams ED
    Front Cell Dev Biol; 2022; 10():858013. PubMed ID: 35493092
    [TBL] [Abstract][Full Text] [Related]  

  • 76. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
    Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.
    O'Hara SM; Moreno JG; Zweitzig DR; Gross S; Gomella LG; Terstappen LW
    Clin Chem; 2004 May; 50(5):826-35. PubMed ID: 14988224
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
    Chistiakov DA; Chekhonin VP
    Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.
    Wu P; Sokoll LJ; Kudrolli TA; Chowdhury WH; Ma R; Liu MM; Rodriguez R; Lupold SE
    Prostate; 2014 Sep; 74(13):1286-1296. PubMed ID: 25065656
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system.
    Ikeda M; Koh Y; Teraoka S; Sato K; Kanai K; Hayata A; Tokudome N; Akamatsu H; Ozawa Y; Akamatsu K; Endo K; Higuchi M; Nakanishi M; Ueda H; Yamamoto N
    Cancer Med; 2020 Mar; 9(6):2122-2133. PubMed ID: 31999390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.